How to buy West Pharmaceutical Services (WST) stocks

West Pharmaceutical Services is a medical instruments & supplies business based in the US. West Pharmaceutical Services shares (WST) are listed on the NYSE and all prices are listed in US Dollars.

Its last market close was $331.40 – an increase of 0.41% over the previous week. West Pharmaceutical Services employs 10,600 staff and has a trailing 12-month revenue of around $2.9 billion.

Our top picks for where to buy West Pharmaceutical Services stock

Buy West Pharmaceutical Services stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

Finder Score for stock trading platforms

To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.

Read the full methodology

Related: Compare the best stock trading platforms in Canada

West Pharmaceutical Services stock price (NYSE: WST)

Use our graph to track the performance of WST stocks over time.

West Pharmaceutical Services stocks at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$331.40
52-week range	$264.65 - $412.94
50-day moving average more info button	$313.77
200-day moving average more info button	$329.57
Wall St. target price	$371.01
PE ratio more info button	48.3388
Dividend yield more info button	$0.8 (0.26%)
Earnings per share (TTM) more info button	$6.73

Is it a good time to buy West Pharmaceutical Services stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dive deeper: Our picks for the best stocks to buy right now in Canada

West Pharmaceutical Services price performance over time

Historical closes compared with the close of $327.01 from 2024-12-19

1 week (2024-12-13)	-0.92%
1 month (2024-11-21)	1.91%
3 months (2024-09-20)	6.12%
6 months (2024-06-21)	-1.73%

1 year (2023-12-21)	-7.56%
2 years (2022-12-21)	40.00%
3 years (2021-12-21)	441.36
5 years (2019-12-20)	119.47%

Is West Pharmaceutical Services stock undervalued or overvalued?

Valuing West Pharmaceutical Services stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of West Pharmaceutical Services's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

West Pharmaceutical Services's P/E ratio

West Pharmaceutical Services's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 48x. In other words, West Pharmaceutical Services shares trade at around 48x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the stock or simply that they're over-valued.

West Pharmaceutical Services's PEG ratio

West Pharmaceutical Services's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 6.0739. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into West Pharmaceutical Services's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.

West Pharmaceutical Services's EBITDA

West Pharmaceutical Services's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $744.7 million.

The EBITDA is a measure of a West Pharmaceutical Services's overall financial performance and is widely used to measure a its profitability.

West Pharmaceutical Services financials

Revenue TTM	$2.9 billion
Operating margin TTM	22.32%
Gross profit TTM	$1.1 billion
Return on assets TTM	10%
Return on equity TTM	17.78%
Profit margin	17.37%
Book value	$37.96
Market Capitalization more info button	$23.6 billion

TTM: trailing 12 months

West Pharmaceutical Services stock dividends

Dividend payout ratio: 11.98% of net profits

Recently West Pharmaceutical Services has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), West Pharmaceutical Services shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In West Pharmaceutical Services's case, that would currently equate to about $0.8 per share.

While West Pharmaceutical Services's payout ratio might seem low, this can signify that West Pharmaceutical Services is investing more in its future growth.

West Pharmaceutical Services's most recent dividend payout was on 19 November 2024. The latest dividend was paid out to all shareholders who bought their stocks by 12 November 2024 (the "ex-dividend date").

Have West Pharmaceutical Services's stocks ever split?

West Pharmaceutical Services's stocks were split on a 2:1 basis on 26 September 2013 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your West Pharmaceutical Services stocks – just the quantity. However, indirectly, the new 50% lower stock price could have impacted the market appetite for West Pharmaceutical Services stocks, which in turn could have impacted West Pharmaceutical Services's stock price.

West Pharmaceutical Services stock price volatility

Over the last 12 months, West Pharmaceutical Services's stocks have ranged in value from as little as $264.6533 up to $412.9386. A popular way to gauge a stock's volatility is its "beta."

Beta is a measure of a stocks volatility in relation to the market. The market (NYSE average) beta is 1, while West Pharmaceutical Services's is 1.003. This would suggest that West Pharmaceutical Services's stocks are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

West Pharmaceutical Services overview

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

Related: New to stock trading? Compare brokers and get tips for investing.

Frequently asked questions

What percentage of West Pharmaceutical Services is owned by insiders or institutions?
Currently 0.583% of West Pharmaceutical Services stocks are held by insiders and 96.779% by institutions. How many people work for West Pharmaceutical Services?
Latest data suggests 10,600 work at West Pharmaceutical Services. When does the fiscal year end for West Pharmaceutical Services?
West Pharmaceutical Services's fiscal year ends in December. Where is West Pharmaceutical Services based?
West Pharmaceutical Services's address is: 530 Herman O. West Drive, Exton, PA, United States, 19341-1147 What is West Pharmaceutical Services's ISIN number?
West Pharmaceutical Services's international securities identification number is: US9553061055 What is West Pharmaceutical Services's CUSIP number?
West Pharmaceutical Services's Committee on Uniform Securities Identification Procedures number is: 953348109

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.